Prospects for the use of oral collagen in the treatment of telogen effluvium
DOI: https://dx.doi.org/10.18565/pharmateca.2024.10.49-54
Kruglova L.S., Bezborodova A.V.
Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation, Moscow, Russia
Background. Telogen effluvium (TE) is one of the most common diseases that lead to hair loss. It is characterized by the premature transition of hair follicles from the anagen phase to the telogen phase, which causes intense hair loss and significantly reduces the quality of life of patients.
Objective. Evaluation of the effectiveness of a combined approach in the treatment of TE using hardware methods and oral administration of hydrolyzed marine collagen.
Methods. The study included 28 women aged 20 to 60 years (mean age 33.5±1.2 years) with a diagnosis of TE. For therapy, a combined approach was used, including hardware methods such as monopolar radiofrequency therapy (once a week), fractional erbium laser (once every two weeks), photodynamic therapy (once a week), and oral administration of hydrolyzed marine collagen NFO. The composition of the dietary supplement is enhanced with vitamins C and D, hyaluronic acid and biotin, which are cofactors for the synthesis of natural collagen.
Results. During the follow-up of patients who received combined therapy using hydrolyzed marine collagen NFO and hardware methods, a significant decrease in hair loss, improvement in hair quality and increase in hair density were noted.
Conclusion. Combined treatment with TE is an effective and safe method that helps improve the condition of the hair and improve the quality of life of patients.
About the Autors
Corresponding author: Larisa S. Kruglova, Dr. Sci. (Med.), Professor, Head of the Department of Dermatovenereology and Cosmetology, Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation, Moscow, Russia; kruglovals@mail.ru
Similar Articles